Quarterly report · Q2

Period2022-01-01 → 2022-06-30
Filed2022-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥840m2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥2.0bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥430m2021-01-01 → 2021-06-30Cons.Net sales
Operating income−¥312m2022-01-01 → 2022-06-30Cons.Operating income
Operating income−¥777m2021-01-01 → 2021-06-30Cons.Operating income
Ordinary income−¥306m2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income−¥523m2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥775m2021-01-01 → 2021-06-30Cons.Ordinary income
Profit before tax−¥349m2022-01-01 → 2022-06-30Cons.Income before income taxes
Profit before tax−¥781m2021-01-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)−¥359m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥534m2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥776m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income−¥359m2022-01-01 → 2022-06-30Cons.Profit loss
Net income−¥776m2021-01-01 → 2021-06-30Cons.Profit loss
Total assets¥5.2bnat 2022-06-30Cons.Assets
Total assets¥5.4bnat 2021-12-31Cons.Assets
Total assets¥3.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥792mat 2022-06-30Cons.Liabilities
Total liabilities¥1.1bnat 2021-12-31Cons.Liabilities
Net assets / equity¥4.4bnat 2022-06-30Cons.Net assets
Net assets / equity¥4.3bnat 2021-12-31Cons.Net assets
Net assets / equity¥3.1bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥3.8bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥4.7bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥3.8bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.2bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.3bnat 2020-12-31dCons.Cash and cash equivalents
Operating cash flow¥585m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.5bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥963m2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥57m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥42m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥34m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥166m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.1bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥102m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-26.532022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.252022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-42.12021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-62.562021-01-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-39.462021-04-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio84.7%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.5%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥286m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥547m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥553m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥235m
jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥922m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥430m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥430m
jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥145m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 439
ItemContextValueUnit
Foreign exchange losses gains ope cfPrior1YTDDuration-5737000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration-20351000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration58195000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration1125012000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-6079000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-2693000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration-1437000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-1814000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration-194505000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration-105334000JPY
Increase decrease in unearned revenue ope cfPrior1YTDDuration-130383000JPY
Increase decrease in unearned revenue ope cfCurrentYTDDuration-137469000JPY
Other net ope cfPrior1YTDDuration8716000JPY
Other net ope cfCurrentYTDDuration1732000JPY
Subtotal ope cfPrior1YTDDuration-1012370000JPY
Subtotal ope cfCurrentYTDDuration594696000JPY
Interest income received ope cfPrior1YTDDuration57000JPY
Interest income received ope cfCurrentYTDDuration57000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-2104000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-2954000JPY
Income taxes paid refund ope cfPrior1YTDDuration43880000JPY
Income taxes paid refund ope cfCurrentYTDDuration-8364000JPY
Proceeds from subsidy ope cfPrior1YTDDuration7200000JPY
Proceeds from subsidy ope cfCurrentYTDDuration-JPY
Other net ope cf subtotalPrior1YTDDuration-JPY
Other net ope cf subtotalCurrentYTDDuration1906000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration-963337000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration585341000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-34184000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-57614000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-155000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-JPY
Other net inv cfPrior1YTDDuration-JPY
Other net inv cfCurrentYTDDuration305000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-34339000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-57309000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-88273000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-120012000JPY
Redemption of bonds fin cfPrior1YTDDuration-14014000JPY
Redemption of bonds fin cfCurrentYTDDuration-14014000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YTDDuration-JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration300374000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-102287000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration166348000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration13891000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration172483000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-1086072000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration866864000JPY
Cash and cash equivalentsPrior2YearInstant4299142000JPY
Cash and cash equivalentsPrior1YearInstant3817834000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass